fbpx

Disclaimer

Stem cell care is a regular clinical practice in the United States and many other countries for more than 25 years and is being used to treat patients with disorders of the blood and blood-forming organs such as sickle cell anemia, thalassemia, leukemia, and lymphomas, etc.

Any opinions or statements offered on this website are for information and education purposes only. Before following any guidance, making any decisions or reaching any conclusions from this web site, you should first consult with your physician.

The information material on this website may not be the most current. We provide general information written in a way to be understandable by a layperson quickly. We make no guarantees about the technical accuracy, completeness, or adequacy of the information contained on this website. If you have any inquiries, questions, or wish to get more thorough or updated information, please call our front desk at (586) 726-9860. We may have more accurate and current information.

The U.S. Department of Health and Human Services (USDHHS) refers to Regenerative Medicine as the next evolution of medical care, with the potential to regenerate irreparably damaged tissue so that they return to full functionality.

The USFDA (U.S. Food and Drug Administration), approved products derived from stem cells. For example, blood-forming stem cells (hematopoietic progenitor cells) derived from cord blood. Currently, the only product to be approved for limited use in the United States is for patients with disorders that affect body systems involved in the production of blood. You can find the FDA-approved stem cell products on the FDA website. Bone marrow also is used for these treatments but is generally not regulated by the FDA for this use.

All stem cell research carried out by MIH, follows strict scientific and ethical guidelines directed and approved by the US NIH (United States National Institute of Health). The most prestigious U.S. Universities perform and peer-review the majority of the Stem Cell research and publications available at “PubMed,” a website managed by the United States National Institute of Health.

Michigan Integrative Health (MIH) also works following the guidelines of the International Society of Stem Cell Research (ISSCR) and the International Society for Cellular Therapy (ISCT).

Our stem cell therapy procedures follow FDA regulations CFR21 Part 1271 (1271.15.b).

MIH also follows the ethical guidelines per the World Medical Association Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects).

This website does not claim that any stem cell application will cure or prevent any medical condition. This website is not evaluated or approved by the US FDA. This website does not provide any medical advice.

It is critically important for everyone to do his or her research to reach an informed decision. It is an entirely voluntary decision to participate in our stem cell care programs.

The testimonials, statements, and opinions presented on this website applied to the individuals depicted only. Results may vary and may not be a representation of the experience of other patients. The testimonials are a representation of each patient experience, but the exact results and experience will be unique and individual to each patient.

Creating a positive and significant impact on the human race is our primary goal. From research to treatment is our purpose.